Quality assessment of surgery for colorectal cancer: Where do we stand?

doi:10.4240/wjgs.v16.i4.982

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 4

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (286)

All Articles published online

The chart showing PDF series, HTML series, Tables (1-2) series.

Item

Count

PDF

HTML

168

Tables (1-2)

Sum=259

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=15

Apr 27, 2024 (publication date) through May 9, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Surgery

ISSN

1948-9366

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Editorial

World J Gastrointest Surg. Apr 27, 2024; 16(4): 982-987
Published online Apr 27, 2024. doi: 10.4240/wjgs.v16.i4.982

Quality assessment of surgery for colorectal cancer: Where do we stand?

Stefan Morarasu, Cristian Livadaru, Gabriel-Mihail Dimofte

Stefan Morarasu, Cristian Livadaru, Gabriel-Mihail Dimofte, The Second Department of Surgical Oncology, Regional Institute of Oncology, Iasi 707483, Romania

Conflict-of-interest statement: The authors declare having no conflicts of interest.

Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.

Corresponding author: Gabriel-Mihail Dimofte, PhD, Professor, The Second Department of Surgical Oncology, Regional Institute of Oncology, 2-4 General Berthelot St, Iasi 707483, Romania. gdimofte@gmail.com

Received: December 17, 2023
Peer-review started: December 17, 2023
First decision: February 3, 2024
Revised: February 5, 2024
Accepted: March 21, 2024
Article in press: March 21, 2024
Published online: April 27, 2024

Core Tip

Core Tip: Quality assurance in colorectal cancer surgery has had a major impact on survival, and it is likely the most important factor contributing to the unprecedented decrease in local recurrences. Due to total mesorectal excision and complete mesocolic excision, we have a set of quality markers that can be used as tools to predict outcomes and guide surgical and oncological management in at-risk patients. While there is strong evidence supporting the value of quality markers, we must promote their use at national and institutional levels as a perquisite of good practice, thus offering our patients the best chances of cure.